🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

FTSE edges higher as Sainsbury's, pharma stocks rally

Published 21/03/2016, 09:48
© Reuters. People walk through the lobby of the London Stock Exchange in London
UK100
-
NXT
-
MKS
-
HIK
-
RIO
-
HOME
-
SHP
-
AAL
-
GSK
-
BHPB
-
ANTO
-
SBRY
-
HG
-
CL
-
FTNMX551030
-
GLEN
-
SNHJ
-

By Kit Rees

LONDON (Reuters) - UK shares inched higher on Monday as gains in the pharmaceutical sector and in grocer Sainsbury's outweighed a fall in mining stocks, which tracked metals prices lower.

After a subdued start to the session, the UK's FTSE 100 index (FTSE) was up 0.1 percent at 0926 GMT, broadly in line with the wider European market.

Britain's second biggest grocer Sainsbury's (L:SBRY) was among the top gainers, up 1.6 percent after it was given a clear run to buy Argos-owner Home Retail (L:HOME) for 1.4 billion pounds ($2 billion) after the market closed last Friday.

Steinhoff International (DE:SNHG), Sainsbury's rival in the bid for the takeover, has pulled out of the race.

"There will be much less upside surprise for the company with Argos in tow down the line. What still remains unclear to us though is the trajectory of underlying Argos profitability, and this will be an important variable over time," Clive Black, head of research at Shore Capital, said in a note.

Shares in Sainsbury's were also boosted by a price target upgrade from broker Nomura. Shares in Home retail gained 1.8 percent.

British retailers Next (L:NXT) and grocer Marks and Spencer (L:MKS) both fell, however, after investment bank UBS cuts its target price on the stocks.

The strongest gainer on the FTSE 100 was pharmaceutical company Shire (L:SHP) which rose 2.5 percent.

"We've seen a plethora of different broker upgrades on (Shire) over the last number of weeks ... I think it's the fact that it has had a very decent Q4," said Brenda Kelly, head analyst at London Capital Group. The company's announcement of a dividend also cheered investors, she added.

Shares in fellow drugmakers Hikma (L:HIK) and GlaxoSmithKline (L:GSK) advanced 1.6 percent and 0.4 percent respectively.

Among top fallers, a stronger dollar hit shares in British mining stocks as dollar-priced crude oil and metals became more expensive for holders of other currencies.

The price of copper dropped from a four-month high reached in the previous session as the dollar rebounded from lows hit after the Federal Reserve kept rates on hold last week. [MET/L]

The British mining index (FTNMX1770) fell 1.8 percent, led lower by Anglo American (L:AAL), Glencore (L:GLEN), Antofagasta (L:ANTO), BHP Billiton (L:BLT) and Rio Tinto (L:RIO), which were all down between 1.3 percent and 3 percent.

The sector is still holding on to gains for the year, up 23.5 percent since the beginning of 2016.

"Unless we see global growth starting to expand and the need for basic resources actually starting to expand more, then we could be looking at a temporary bottom," London Capital Group's Kelly said.

ADVISORY- Reuters plans to replace intra-day European and UK stock market reports with a Live Markets blog on Eikon (see cpurl://apps.cp./cms/?pageId=livemarkets for site in development). In a real-time, multimedia format from 0600 London time through to the 1630 closing bell, it will include the best of our market reporting, Stocks Buzz service, Eikon graphics, Reuters pictures, eye-catching research and market zeitgeist. Breaking news and dramatic market moves will continue to be alerted to all clients and we will continue to provide a short opening story and comprehensive closing reports.

If you have any thoughts, suggestions or feedback on this, please email mike.dolan@thomsonreuters.com. 

© Reuters. People walk through the lobby of the London Stock Exchange in London

                 Mike Dolan, Markets Editor EMEA.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.